assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_000512205.2_ASM51220v2	NZ_CP006644	Sphingomonas sanxanigenens DSM 19645 = NX02 chromosome, complete genome	1	648332-649489	1,1,1	PILER-CR,CRISPRCasFinder,CRT	no	cas9,cas2	cas9,cas2,RT,csa3,DEDDh,DinG,cas3	 Type II-B, or Type II-C?,Type II-A,Type II-C,Type II-B	ACCATAGCTGTTCAGAGATCGCGGTCCAGCGGCAAC,ACCATAGCTGTTCAGAGATCGCGGTCCAGCGGCAAC,ACCATAGCTGTTCAGAGATCGCGGTCCAGCGGCAAC	36,36,36	0	0	NA	NA	NA:NA:NA	16,17,17	17	TypeII-B,orTypeII-C?,TypeII-A,TypeII-C,TypeII-B	cas9,cas2,RT,csa3,DEDDh,DinG,cas3	NA|64aa|up_9|NZ_CP006644.1_638143_638335_-,NA|122aa|up_7|NZ_CP006644.1_639200_639566_+,NA|240aa|up_6|NZ_CP006644.1_639562_640282_+,NA|129aa|up_5|NZ_CP006644.1_640286_640673_+,NA|208aa|up_3|NZ_CP006644.1_641168_641792_+,NA|531aa|up_2|NZ_CP006644.1_641796_643389_+,NA|548aa|down_1|NZ_CP006644.1_650333_651977_-,NA|193aa|down_2|NZ_CP006644.1_652040_652619_-,NA|90aa|down_4|NZ_CP006644.1_654383_654653_+,NA|227aa|down_5|NZ_CP006644.1_655093_655774_-,NA|672aa|down_6|NZ_CP006644.1_655799_657815_-,NA|502aa|down_7|NZ_CP006644.1_657814_659320_-,NA|198aa|down_8|NZ_CP006644.1_659384_659978_-,NA|270aa|down_9|NZ_CP006644.1_660732_661542_+	NA|64aa|up_9|NZ_CP006644.1_638143_638335_-	NA	NA|158aa|up_8|NZ_CP006644.1_638591_639065_-	PRK12270, kgd, multifunctional oxoglutarate decarboxylase/oxoglutarate dehydrogenase thiamine pyrophosphate-binding subunit/dihydrolipoyllysine-residue succinyltransferase subunit	NA|122aa|up_7|NZ_CP006644.1_639200_639566_+	NA	NA|240aa|up_6|NZ_CP006644.1_639562_640282_+	NA	NA|129aa|up_5|NZ_CP006644.1_640286_640673_+	NA	NA|153aa|up_4|NZ_CP006644.1_640669_641128_+	pfam03965, Penicillinase_R, Penicillinase repressor	NA|208aa|up_3|NZ_CP006644.1_641168_641792_+	NA	NA|531aa|up_2|NZ_CP006644.1_641796_643389_+	NA	cas9|1104aa|up_1|NZ_CP006644.1_643672_646984_+	cd09643, Csn1, CRISPR/Cas system-associated protein Cas9	cas2|113aa|up_0|NZ_CP006644.1_647918_648257_+	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	NA|228aa|down_0|NZ_CP006644.1_649621_650305_+	COG0664, Crp, cAMP-binding proteins - catabolite gene activator and regulatory subunit of cAMP-dependent protein kinases [Signal transduction mechanisms]	NA|548aa|down_1|NZ_CP006644.1_650333_651977_-	NA	NA|193aa|down_2|NZ_CP006644.1_652040_652619_-	NA	NA|529aa|down_3|NZ_CP006644.1_652615_654202_-	pfam08937, DUF1863, MTH538 TIR-like domain (DUF1863)	NA|90aa|down_4|NZ_CP006644.1_654383_654653_+	NA	NA|227aa|down_5|NZ_CP006644.1_655093_655774_-	NA	NA|672aa|down_6|NZ_CP006644.1_655799_657815_-	NA	NA|502aa|down_7|NZ_CP006644.1_657814_659320_-	NA	NA|198aa|down_8|NZ_CP006644.1_659384_659978_-	NA	NA|270aa|down_9|NZ_CP006644.1_660732_661542_+	NA
GCF_000512205.2_ASM51220v2	NZ_CP006644	Sphingomonas sanxanigenens DSM 19645 = NX02 chromosome, complete genome	2	3181034-3181218	2	CRISPRCasFinder	no		cas9,cas2,RT,csa3,DEDDh,DinG,cas3	Orphan	CGGCAACGACACCCTCAACGGCG	23	0	0	NA	NA	NA	3	3	Orphan	cas9,cas2,RT,csa3,DEDDh,DinG,cas3	NA,NA	NA|260aa|up_9|NZ_CP006644.1_3161796_3162576_-	COG2186, FadR, Transcriptional regulators [Transcription]	NA|1082aa|up_8|NZ_CP006644.1_3162664_3165910_+	PRK09525, lacZ, beta-galactosidase	NA|314aa|up_7|NZ_CP006644.1_3165906_3166848_+	pfam16153, DUF4861, Domain of unknown function (DUF4861)	NA|421aa|up_6|NZ_CP006644.1_3166871_3168134_+	pfam10022, DUF2264, Uncharacterized protein conserved in bacteria (DUF2264)	NA|290aa|up_5|NZ_CP006644.1_3168118_3168988_-	pfam17765, MLTR_LBD, MmyB-like transcription regulator ligand binding domain	NA|299aa|up_4|NZ_CP006644.1_3169078_3169975_+	cd05262, SDR_a7, atypical (a) SDRs, subgroup 7	NA|242aa|up_3|NZ_CP006644.1_3170065_3170791_-	pfam12697, Abhydrolase_6, Alpha/beta hydrolase family	NA|416aa|up_2|NZ_CP006644.1_3171067_3172315_+	COG2814, AraJ, Arabinose efflux permease [Carbohydrate transport and metabolism]	NA|224aa|up_1|NZ_CP006644.1_3172330_3173002_-	TIGR02018, Histidine_utilization_repressor, histidine utilization repressor, proteobacterial	NA|860aa|up_0|NZ_CP006644.1_3173160_3175740_-	cd06240, M14-like, Peptidase M14-like domain; uncharacterized subgroup	NA|189aa|down_0|NZ_CP006644.1_3184771_3185338_-	pfam05962, HutD, HutD	NA|556aa|down_1|NZ_CP006644.1_3185340_3187008_-	PRK05414, PRK05414, urocanate hydratase; Provisional	NA|275aa|down_2|NZ_CP006644.1_3187004_3187829_-	TIGR02017, hutG_amidohyd, N-formylglutamate amidohydrolase	NA|513aa|down_3|NZ_CP006644.1_3187825_3189364_-	PRK09367, PRK09367, histidine ammonia-lyase; Provisional	NA|401aa|down_4|NZ_CP006644.1_3189348_3190551_-	PRK09356, PRK09356, imidazolonepropionase; Validated	NA|455aa|down_5|NZ_CP006644.1_3190640_3192005_+	PRK09229, PRK09229, N-formimino-L-glutamate deiminase; Validated	NA|692aa|down_6|NZ_CP006644.1_3192205_3194281_-	PRK02999, PRK02999, malate synthase G; Provisional	NA|403aa|down_7|NZ_CP006644.1_3194407_3195616_+	PRK07338, PRK07338, hydrolase	NA|341aa|down_8|NZ_CP006644.1_3195612_3196635_+	pfam04958, AstA, Arginine N-succinyltransferase beta subunit	NA|166aa|down_9|NZ_CP006644.1_3196663_3197161_-	cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands
